Comparison of Administration of 8-Milligram and 4-Milligram Intranasal Naloxone by Law Enforcement During Response to Suspected Opioid Overdose — New York, March 2022–August 2023 | MMWR - CDC

This report describes real-world comparisons of survival, the average number of doses administered, the presence of postnaloxone signs and symptoms, and hospital transport refusal among people receiving 8-mg and 4-mg intranasal naloxone.